Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1519, 2006-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Risk-Benefit Assessment of Abciximab in Angioplasty
By Kleiman N.S.
Drug Safety, Vol. 20, Iss. 1, 1999-01 ,pp. :
Access to resources
Recommend
Carvedilol: beneficial effect on LV remodeling
Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. :
Abciximab: effective in refractory unstable angina
Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. :
Abciximab: transradial route best during angioplasty?
Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. :
Abciximab for high-risk patients: effective at a cost
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :